Forskning
Udskriv Udskriv
Switch language
  1. Region Hovedstaden
  2. Publikationer
  3. Effects of first-line enzaluta...
  4. Citationsformater
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Effects of first-line enzalutamide and abiraterone plus prednisone on health-related quality-of-life in men with metastatic castration-resistant prostate cancer: a systematic review and meta-analyses

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

Harvard

Ternov, KK, Nolsøe, AB, Bratt, O, Fode , M, Lindberg, H, Kistorp, CM, Palapattu, G, Klausen, TW, Sønksen, JOR & Østergren , PB 2019, 'Effects of first-line enzalutamide and abiraterone plus prednisone on health-related quality-of-life in men with metastatic castration-resistant prostate cancer: a systematic review and meta-analyses', Herlev, Danmark, 27/11/2019, .

APA

Ternov, K. K., Nolsøe, AB., Bratt, O., Fode , M., Lindberg, H., Kistorp, C. M., ... Østergren , P. B. (2019). Effects of first-line enzalutamide and abiraterone plus prednisone on health-related quality-of-life in men with metastatic castration-resistant prostate cancer: a systematic review and meta-analyses. Abstract fra Forskningens Dag, Herlev, Danmark.

CBE

Ternov KK, Nolsøe AB, Bratt O, Fode M, Lindberg H, Kistorp CM, Palapattu G, Klausen TW, Sønksen JOR, Østergren PB. 2019. Effects of first-line enzalutamide and abiraterone plus prednisone on health-related quality-of-life in men with metastatic castration-resistant prostate cancer: a systematic review and meta-analyses. Abstract fra Forskningens Dag, Herlev, Danmark.

MLA

Ternov, Klara Kvorning o.a.. Effects of first-line enzalutamide and abiraterone plus prednisone on health-related quality-of-life in men with metastatic castration-resistant prostate cancer: a systematic review and meta-analyses. 2019.

Vancouver

Ternov KK, Nolsøe AB, Bratt O, Fode M, Lindberg H, Kistorp CM o.a.. Effects of first-line enzalutamide and abiraterone plus prednisone on health-related quality-of-life in men with metastatic castration-resistant prostate cancer: a systematic review and meta-analyses. 2019. Abstract fra Forskningens Dag, Herlev, Danmark.

Author

Ternov, Klara Kvorning ; Nolsøe, AB ; Bratt, O ; Fode , Mikkel ; Lindberg, Henriette ; Kistorp, Caroline Michaela ; Palapattu, Ganesh ; Klausen, Tobias Wirenfeldt ; Sønksen, Jens Otto Reimers ; Østergren , Peter Busch. / Effects of first-line enzalutamide and abiraterone plus prednisone on health-related quality-of-life in men with metastatic castration-resistant prostate cancer: a systematic review and meta-analyses. Abstract fra Forskningens Dag, Herlev, Danmark.

Bibtex

@conference{d9a4e23ae77c4773ad4215095f168d7c,
title = "Effects of first-line enzalutamide and abiraterone plus prednisone on health-related quality-of-life in men with metastatic castration-resistant prostate cancer: a systematic review and meta-analyses",
author = "Ternov, {Klara Kvorning} and AB Nols{\o}e and O Bratt and Mikkel Fode and Henriette Lindberg and Kistorp, {Caroline Michaela} and Ganesh Palapattu and Klausen, {Tobias Wirenfeldt} and S{\o}nksen, {Jens Otto Reimers} and {\O}stergren, {Peter Busch}",
year = "2019",
language = "English",
note = "Forskningens Dag ; Conference date: 27-11-2019",

}

RIS

TY - ABST

T1 - Effects of first-line enzalutamide and abiraterone plus prednisone on health-related quality-of-life in men with metastatic castration-resistant prostate cancer: a systematic review and meta-analyses

AU - Ternov, Klara Kvorning

AU - Nolsøe, AB

AU - Bratt, O

AU - Fode , Mikkel

AU - Lindberg, Henriette

AU - Kistorp, Caroline Michaela

AU - Palapattu, Ganesh

AU - Klausen, Tobias Wirenfeldt

AU - Sønksen, Jens Otto Reimers

AU - Østergren , Peter Busch

PY - 2019

Y1 - 2019

M3 - Conference abstract for conference

ER -

ID: 60123539